Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969569718> ?p ?o ?g. }
- W2969569718 endingPage "322" @default.
- W2969569718 startingPage "305" @default.
- W2969569718 abstract "Delivery to the target site and adversities related to off-target exposure have made the road to clinical success and approval of antisense oligonucleotide (AON) therapies challenging. Various classes of AONs have distinct chemical features and pharmacological properties. Understanding the similarities and differences in pharmacokinetics (PKs) among AON classes is important to make future development more efficient and may facilitate regulatory guidance of AON development programs. For the class of 2'-O-methyl phosphorothioate (2OMe PS) RNA AONs, most nonclinical and clinical PK data available today are derived from development of exon skipping therapies for Duchenne muscular dystrophy (DMD). While some publications have featured PK aspects of these AONs, no comprehensive overview is available to date. This article presents a detailed review of absorption, distribution, metabolism, and excretion of 2OMe PS AONs, compiled from publicly available data and previously unpublished internal data on drisapersen and related exon skipping candidates in preclinical species and DMD patients. Considerations regarding drug-drug interactions, toxicokinetics, and pharmacodynamics are also discussed. From the data presented, the picture emerges of consistent PK properties within the 2OMe PS class, predictable behavior across species, and a considerable overlap with other single-stranded PS AONs. A level of detail on muscle as a target tissue is provided, which was not previously available. Furthermore, muscle biopsy samples taken in DMD clinical trials allowed confirmation of the applicability of interspecies scaling approaches commonly applied in the absence of clinical target tissue data." @default.
- W2969569718 created "2019-08-29" @default.
- W2969569718 creator A5016836718 @default.
- W2969569718 creator A5029017753 @default.
- W2969569718 creator A5072615914 @default.
- W2969569718 creator A5087607269 @default.
- W2969569718 creator A5087938003 @default.
- W2969569718 creator A5088953887 @default.
- W2969569718 date "2019-12-01" @default.
- W2969569718 modified "2023-09-29" @default.
- W2969569718 title "The Pharmacokinetics of 2′-<i>O</i>-Methyl Phosphorothioate Antisense Oligonucleotides: Experiences from Developing Exon Skipping Therapies for Duchenne Muscular Dystrophy" @default.
- W2969569718 cites W1441718521 @default.
- W2969569718 cites W1689841231 @default.
- W2969569718 cites W1755223125 @default.
- W2969569718 cites W1908974948 @default.
- W2969569718 cites W1952915322 @default.
- W2969569718 cites W1997188614 @default.
- W2969569718 cites W1997730532 @default.
- W2969569718 cites W1999638106 @default.
- W2969569718 cites W2004909530 @default.
- W2969569718 cites W2006167464 @default.
- W2969569718 cites W2010757394 @default.
- W2969569718 cites W2020713872 @default.
- W2969569718 cites W2021905258 @default.
- W2969569718 cites W2029005246 @default.
- W2969569718 cites W2032596014 @default.
- W2969569718 cites W2032810973 @default.
- W2969569718 cites W2033425827 @default.
- W2969569718 cites W2034425055 @default.
- W2969569718 cites W2044851147 @default.
- W2969569718 cites W2047366876 @default.
- W2969569718 cites W2047922381 @default.
- W2969569718 cites W2048680477 @default.
- W2969569718 cites W2053210596 @default.
- W2969569718 cites W2059310361 @default.
- W2969569718 cites W2064808830 @default.
- W2969569718 cites W2066501816 @default.
- W2969569718 cites W2070104988 @default.
- W2969569718 cites W2079266971 @default.
- W2969569718 cites W2083018473 @default.
- W2969569718 cites W2085726823 @default.
- W2969569718 cites W2101604665 @default.
- W2969569718 cites W2109050641 @default.
- W2969569718 cites W2114775015 @default.
- W2969569718 cites W2117224856 @default.
- W2969569718 cites W2123034315 @default.
- W2969569718 cites W2132137078 @default.
- W2969569718 cites W2132343975 @default.
- W2969569718 cites W2141695132 @default.
- W2969569718 cites W2149741786 @default.
- W2969569718 cites W2154041187 @default.
- W2969569718 cites W2157085976 @default.
- W2969569718 cites W2158041351 @default.
- W2969569718 cites W2161599977 @default.
- W2969569718 cites W2165586566 @default.
- W2969569718 cites W2166217372 @default.
- W2969569718 cites W2177281686 @default.
- W2969569718 cites W2180191687 @default.
- W2969569718 cites W2181479067 @default.
- W2969569718 cites W2185895765 @default.
- W2969569718 cites W2188384476 @default.
- W2969569718 cites W2239874339 @default.
- W2969569718 cites W2290548509 @default.
- W2969569718 cites W2294864494 @default.
- W2969569718 cites W2328404863 @default.
- W2969569718 cites W2336977304 @default.
- W2969569718 cites W2411634967 @default.
- W2969569718 cites W2473879127 @default.
- W2969569718 cites W2482598541 @default.
- W2969569718 cites W2511893227 @default.
- W2969569718 cites W2553226331 @default.
- W2969569718 cites W2576942864 @default.
- W2969569718 cites W2583555090 @default.
- W2969569718 cites W2583673989 @default.
- W2969569718 cites W2587247473 @default.
- W2969569718 cites W2592524531 @default.
- W2969569718 cites W2596267980 @default.
- W2969569718 cites W2600519390 @default.
- W2969569718 cites W2604438258 @default.
- W2969569718 cites W2619533159 @default.
- W2969569718 cites W2730536591 @default.
- W2969569718 cites W2743090929 @default.
- W2969569718 cites W2753614680 @default.
- W2969569718 cites W2763718005 @default.
- W2969569718 cites W2770396564 @default.
- W2969569718 cites W2771932281 @default.
- W2969569718 cites W2774788400 @default.
- W2969569718 cites W2788751517 @default.
- W2969569718 cites W2789114047 @default.
- W2969569718 cites W2799526435 @default.
- W2969569718 cites W2799858598 @default.
- W2969569718 cites W2801923570 @default.
- W2969569718 cites W2804754769 @default.
- W2969569718 cites W2805701934 @default.
- W2969569718 cites W2837419728 @default.
- W2969569718 cites W2896199800 @default.
- W2969569718 cites W2900134397 @default.
- W2969569718 cites W2900887638 @default.